Biocure Technology Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was CAD 0.113162 million compared to CAD 0.288068 million a year ago.
For the nine months, net income was CAD 2.19 million compared to net loss of CAD 0.873092 million a year ago. Basic earnings per share from continuing operations was CAD 0.02 compared to basic loss per share from continuing operations of CAD 0.01 a year ago. Diluted earnings per share from continuing operations was CAD 0.02.